Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T12:21:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    2%
    Check dated 2024-12-07T10:29:40.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, lung cancer, and medical resources have been removed, indicating a potential shift in focus or resource availability on the website.
    Difference
    3%
    Check dated 2024-11-23T03:51:34.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding numerous links to resources related to genetics, lung cancer, and various PubMed articles, while removing the previous version 2.12.1.
    Difference
    3%
    Check dated 2024-11-15T22:17:53.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.1, with the removal of a resource on Cabozantinib by Andrea Ardizzoni.
    Difference
    0.6%
    Check dated 2024-11-01T11:15:12.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T00:55:19.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.